SCHEMBL20635566

SCHEMBL20635566

CSNc1ccc(-c2cnc3[nH]cc(-c4ccc5[nH]ccc5c4)c3c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 18/20 0.74
DYRK1A Q13627 2/20 0.71
DYRK2 Q92630 2/20 0.71
DYRK1B Q9Y463 2/20 0.71
CYP3A4 P08684 3/20 0.67
CYP2D6 P10635 2/20 0.67
LRRK2 Q5S007 3/20 0.66
CYP2C9 P11712 1/20 0.66
CLK1 P49759 1/20 0.64
IKBKB O14920 2/20 0.60
CHUK O15111 2/20 0.60
ABL1 P00519 2/20 0.60
INSR P06213 2/20 0.60
CDK2 P24941 2/20 0.60
FLT3 P36888 2/20 0.60
SGK1 O00141 1/20 0.60
AURKA O14965 1/20 0.60
PRKAB2 O43741 1/20 0.60
ROCK2 O75116 1/20 0.60
NTRK1 P04629 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723789 0.86 MAP3K11 (1.00) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL721629 0.84 MAP3K11 (1.00) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL723792 0.83 MAP3K11 (0.71) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL722074 0.83 MAP3K11 (0.71) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL12763475 0.83 MAP3K11 (0.83) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL724304 0.83 MAP3K11 (0.83) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL722261 0.81 MAP3K11 (0.80) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL720976 0.81 MAP3K11 (1.00) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL17226871 0.80 MAP3K11 (0.81) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4
SCHEMBL723923 0.80 MAP3K11 (1.00) MAP3K11DYRK1ADYRK2DYRK1BCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925319-B1 MIXED LINEAGE KINASE INHIBITORS FOR HIV/AIDS THERAPIES UNIV ROCHESTER (US) 2019-01-09 EP disclosed